Biospectal Selected as One of Ten Finalists for the “Saving Lives at Birth” 2018 Grand Challenge

Biospectal was recently selected from more than five hundred applicants to present with our partner team at the Saving Lives at Birth Global Grand Challenge DEVELOPMENTxCHANGE conference in Washington, D.C. Saving Lives at Birth is focused on identifying and scaling transformative prevention and treatment approaches for pregnant women and newborns. It brings together the U.S. Agency for International Development (USAID), the Government of Norway (Norad), the Bill and Melinda Gates Foundation, Grand Challenges Canada, the U.K. Department of International Development (DFID), and the Korea International Cooperation Agency (KOICA).

The team’s proposal is to support an independent field validation study through One Kenya, Limited, and the World Health Organization to integrate the Biospectal’s smartphone based optical blood pressure solution with World Health Organization’s OpenSRP electronic medical record and longitudinal decision support and patient record system in Tanzania and Indonesia. This will serve as a springboard for wider deployment across sites supporting maternal health in low and low to middle income countries.

”We are thrilled to be able to bring our software technology to a global setting for low resource populations,” said Dr. Patrick Schoettker, co-founder and father of Biospectal’s optical blood pressure vision. “We are intent on democratizing diagnostic sensing for a global population. It’s exciting and core to our mission as co-founders to make a global impact and to enable improvement of the standard of care for all populations. Smartphones are everywhere in the world, and we can piggy back on that technology enable hypertension management with a device people already have in their pocket.”

Biospectal will be joining other current innovators working with Saving Lives at Birth, including the nine other finalists and ten award recipients selected previously in Round 8.

For more information, see: